Paul Hastings has secured victory for its client Mitsubishi Chemical Group (MCG) following a four-year long international arbitration battle in London.

MCG, based in Japan, announced the arbitration award entitled it to 126 billion yen ($935 million) in royalty payments from Novartis, a pharmaceutical giant based in Switzerland.